Xellar Biosystems

Company Deals

Bio-Sincerity Partners with Xellar on AI Organoid Chip Drug Discovery Platform

Fineline Cube Jan 6, 2026

Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. (SHE: 301096) and Xellar Biosystems announced a strategic cooperation agreement...

Company Deals

Hisun and ECNU Forge AI Drug Discovery Partnership

Policy / Regulatory

NMPA Issues Priority Review Guidelines for Clinically Urgent Overseas Drugs

Company Deals Drug

Sciclon Licenses Augtyro Promotion Rights from Zai Lab for China Market

Company Drug

Hengrui’s Retlirafusp α Wins NMPA Approval for First-Line Gastric Cancer